Versant Vantage I GP, L.P.
CIK 1777651 · last filed 2024-10-30
Versant Vantage I GP, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing, for GLUE, was dated Oct 30, 2024. Across all open-market trades the lifetime net is −$38.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $106.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$106.28M
4
6
-$38.32M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GLUE | 10%+ Owner | 5,720,827 | $18.23 | $104.32M | -$53.32M | 2 | 2024-10-30 |
| Oyster Point Pharma, Inc. (OYST) Delisted | 10%+ Owner | 0 | $11.17 | $0 | $0 | 1 | 2023-01-04 |
| Repare Therapeutics Inc. (RPTX) Delisted | 10%+ Owner | 2,977,733 | $2.65 | $7.89M | $0 | 2 | 2021-06-03 |
| APRE | 10%+ Owner | 2,852,656 | $0.69 | $1.96M | $15.00M | 1 | 2019-10-07 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-30 | GLUE | Mixed | −9,266,112 | -$8.95M | EDGAR |
| 2024-09-24 | GLUE | Sell (S) | −6,795,396 | -$44.37M | EDGAR |
| 2023-01-04 | Oyster Point Pharma, Inc. (OYST) Delisted | U | −32,918,562 | $0 | EDGAR |
| 2021-06-03 | Repare Therapeutics Inc. (RPTX) Delisted | Other (J) | −225,000 | $0 | EDGAR |
| 2021-05-07 | Repare Therapeutics Inc. (RPTX) Delisted | Other (J) | −722,238 | $0 | EDGAR |
| 2019-10-07 | APRE | Mixed | +8,519,958 | $15.00M | EDGAR |